#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    White matter lesion Stargardt's disease Demyelination Li-Fraumeni syndrome Nasopharyngeal cancer Vernal keratoconjunctivitis Thrombotic thrombocytopenic purpura Antisynthetase syndrome Kaposi's sarcoma Myeloproliferative neoplasm Anaplastic thyroid cancer Neuronal ceroid lipofuscinosis Osteopetrosis Multiple system atrophy Thalassaemia beta More trials…

    Learn about Rare Diseases

    Cytokine release syndrome Brain stem glioma – Basic Information Rhabdoid tumour – Treatment Wolfram syndrome – Basic Information Mucous membrane pemphigoid – Life with Disease IgA nephropathy – Life with Disease Hereditary angioedema with C1 esterase inhibitor deficiency – Life with Disease Hepatic angiosarcoma – Life with Disease Soft tissue sarcoma – Treatment Extranodal marginal zone B-cell lymphoma (MALT type) More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Nitroprusside Dihydrate Nortriptyline Hydrochloride Mepolizumab Poa Pratensis POTASSIUM CLAVULANATE Elexacaftor Imatinib Opevesostat Tosilate Azd0901 Rtp-026 Sodium Levetiracetam Sabestomig Maraviroc YL201 Hhalpc Rocatinlimab Naloxone Hydrochloride Tucatinib AZD3632 ATOVAQUONE More therapies…

    Learn about Your Condition

    Hepatic angiosarcoma Colon cancer stage III Metabolic surgery Pancreatic fistula Prostate cancer metastatic Neutropenia Restless legs syndrome Febrile neutropenia Progressive supranuclear palsy Hypopituitarism Breast cancer Lymphoma Acute myeloid leukaemia Chronic coronary syndrome Haemodynamic instability More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • Study on Preventing BK Virus Infection in Kidney Transplant Patients Using Mycophenolic Acid, Mycophenolate Mofetil, and Sirolimus

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Complications of transplanted kidney
    Investigated Drugs:
    • Sirolimus
    • Mycophenolic Acid
    • Mycophenolate Mofetil
    Spain

  • Study on the Effectiveness and Safety of Bemnifosbuvir for High-Risk COVID-19 Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • Bemnifosbuvir Hemisulfate
    • Nirmatrelvir
    Germany Latvia The Netherlands Romania Spain Sweden

  • Study on BJT-778 for Patients with Chronic Hepatitis B and D Infections

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Chronic hepatitis B
    • Hepatitis D
    Investigated Drugs:
    • Bjt-778
    • Sodium Chloride
    Bulgaria France Romania

  • Study on the Safety and Effectiveness of Bemnifosbuvir and Ruzasvir for Patients with Chronic Hepatitis C

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Chronic hepatitis C
    Investigated Drugs:
    • Bemnifosbuvir Hemisulfate
    • Ruzasvir
    Germany Romania Spain

  • Study on Long-Acting Cabotegravir and Rilpivirine for HIV Patients in Spain: Evaluating Out-of-Hospital Treatment Options

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Cabotegravir Sodium
    • Cabotegravir
    • Rilpivirine
    Spain

  • Study on Valaciclovir to Prevent Congenital CMV Infection in Pregnant Women with First Trimester CMV Infections

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Cytomegalovirus infection
    Investigated Drugs:
    • Valaciclovir
    Belgium
Previous Page
1 … 47 48 49 50 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!